NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Brazilian Reality of Hepatocellular Carcinoma

CompletedN/A

Sponsor: AstraZeneca

Conditions: Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage, Hepatocellular Carcinoma Stage I, Hepatocellular Carcinoma Stage II, Hepatocellular Carcinoma Stage III

Countries: Brazil

National, multicenter, retrospective, non-randomized observational study (Real World Evidence-RWE) with the purpose of analyzing the epidemiological profile of Hepatocellular Carcinomas (BCLC A, B or C), clinical management, progression profile and overall survival of castrated patients treated in national oncology care reference centers, within the last 6 years (between 2017 to 2022).

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Male and female;
* Above 18 years old;
* Hepatocellular carcinoma diagnosis (confirmed by biopsy or imaging);

Exclusion Criteria:

* Fibrollamelar carcinoma, hepatoblastoma, intrahepatic cholangiocarcinoma, neuroendocrine tumors or other less common types of liver tumors;
* Patients with incomplete staging data;
* Patients with only 1 visit to the participating site healthcare service, with loss to follow-up prior to the second visit to the participating site healthcare service;
* Previous treatment for hepatocellular carcinoma in another institution;
* Treatment with investigational drugs in a clinical trial.

Locations (11)

Barretos, Brazil
Belo Horizonte, Brazil
Curitiba, Brazil
Natal, Brazil
Porto Alegre, Brazil
Recife, Brazil
Rio de Janeiro, Brazil
Salvador, Brazil
São Bernardo do Campo, Brazil
São Paulo, Brazil
Vitória, Brazil